Citi equity have downgraded US and UK stocks to a neutral rating from overweight, while upgrading European stocks to overweight. Citi notes that European stocks are trading at a significant discount compared to US stocks and are pricing in a more reasonable earnings growth path. The strategists had previously upgraded US stocks last quarter but the strong year-to-date rally has led them to return to the sidelines.
Citi believes that megacap growth stocks are poised for a pullback, and there are still risks of a US recession. Citi sees a 5% earnings per share (EPS) contraction globally in 2023, followed by a modest 5% expansion in 2024 and expects a slowdown in EPS growth rather than a full recession, but note that risks to the outlook are more balanced now. In terms of sectors, the strategists recommend a portfolio focused on a mix of quality and selective cyclicals and have also downgraded the IT sector to neutral due to the potential pullback in megacap growth, but suggest being prepared to buy back on dips.
Start investing today or test a free demo
Open real account TRY DEMO Download mobile app Download mobile appThe material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.